Cargando…
Identification and Validation of N6-Methyladenosine-Related Biomarkers for Bladder Cancer: Implications for Immunotherapy
N6-methyladenosine (m(6)A) has emerged as one of the most important modifications of RNA. Based on the expression of 23 different modes of m(6)A regulatory factors, we identified three different m(6)A modification patterns in bladder cancer. The effects of the three different modes of m(6)A modifica...
Autores principales: | Deng, Hongyu, Tang, Faqing, Zhou, Ming, Shan, Dongyong, Chen, Xingyu, Cao, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924666/ https://www.ncbi.nlm.nih.gov/pubmed/35311150 http://dx.doi.org/10.3389/fonc.2022.820242 |
Ejemplares similares
-
Transcriptome-Wide Map of N(6)-Methyladenosine Methylome Profiling in Human Bladder Cancer
por: Li, Aolin, et al.
Publicado: (2021) -
Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis
por: Kang, Yao, et al.
Publicado: (2021) -
Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
por: Chen, Yujia, et al.
Publicado: (2022) -
Molecular Characterization and Clinical Relevance of N(6)-Methyladenosine Regulators in Metastatic Prostate Cancer
por: Liu, Qiwei, et al.
Publicado: (2022) -
Landscape of N(6)-Methyladenosine Modification Patterns in Human Ameloblastoma
por: Niu, Xing, et al.
Publicado: (2020)